Françoise Howe

"We now know that cancer does not come from nowhere." Prof Sarah Blagden, director of a new research collaboration between pharma giant GSK and the University of Oxford, tells #R4Today about the development of a new 'pre-cancer' vaccine that could target the disease earlier.

How to get your research funded? We heard insights from our panel: Talisia Quallo @CRUKResearch Florence Theberge @The_MRC Janette Rawlinson @OxfordCancer PPI @FrancoiseSHowe #oxcode Chaired by @sarah_blagden   #oxcode24

It’s hard to believe that OxCODE has been going for 5 years already! We’re celebrating with a 2-day symposium of talks, panel discussions, posters and networking. Looking forward to some excellent science! #oxcode24 @OxfordCancer

🚀The wait is over: registration is open for our second annual Cancer Prevention Research Conference! Get your ticket & join us in London to discuss the latest concepts in cancer prevention research. Register today: bit.ly/3OAqjLS #PrevConf25 | @AmericanCancer

Our latest episode explores research that identified 250+ genes that play a crucial role in bowel cancer, offering hope for prevention, screening and targeted treatments. Tune in as our guests discuss the findings and their impact 🎙️ Listen here: ow.ly/qpMu50Ua4hY

💡 Jens Rittscher (@JensRittscher) is leveraging AI to analyze endoscopy images for Barrett’s esophagus. 🤖🔬 His lab focuses on automated quantification for data-driven phenotyping, with exciting potential to extend into spatial transcriptomics and thicker tissue slices—advancing biomarker discovery. 🧬📊 #AIinMedicine #Endoscopy #ImageAnalysis #BarrettsEsophagus #EDxConf24 | @CRUKresearch | @OHSUKnight | @UniofOxford -pds

Oxford Centre for Cancer Early Detection and Prevention Symposium 10-11th December, Oxford Keynote speakers: Victor Velculescu @JohnsHopkins, Sam Janes @uclmedsci, Molly Stevens @KavliOxford and @GeorgiaBBlack @QMUL_WIPH Abstracts due: 8th Nov Register ⬇️ eventbrite.co.uk/e/oxford-centr…

'Thanks to this funding, our research can take a big step forward towards a viable vaccine for ovarian cancer.' Professor Ahmed Ahmed @MRC_WIMM comments on new funding from @CRUKresearch to create the world’s first vaccine to prevent #OvarianCancer. 👇 cancer.ox.ac.uk/news/funding-t…

#InTheNews We’ve awarded researchers at the @UniofOxford up to £600,000 to create the world’s first vaccine to prevent ovarian cancer. OvarianVax is a vaccine that will teach the immune system to recognise and attack the earliest stages of ovarian cancer.

After winning #PrevConf24 poster prize, Zhe Huang (@UniofOxford) talked to us about his work on investigating the proteomic profiles of #ProstateCancer, his trip to Boston and the story behind his early career. Read more👇

David Church & Simon Leedham will use a Biology to Prevention Award to work on a precision prevention vaccination strategy for Lynch syndrome. They will define candidate frameshift peptides and determine mechanisms of immune escape. @leedham_simon | @UniofOxford | #CRUKFunded

Exciting progress for those of us with Lynch syndrome! As 1 of 4 in the PPI group contributing to this research, it’s brilliant that the researchers have listened to us. A potential vaccine that could prevent not just bowel cancer, but also womb cancer! 🙌#LynchSyndrome #PPI

@sarah_blagden and LynchVax PPI representative @anna_fry speaking at the @OBN_UK @BioEscalator event arguing the time is right for cancer precision prevention trials @OxfordCancer @OCTO_Oxford

@OCTO_Oxford’s key features for precision prevention trials, as presented by @sarah_blagden #PrevConf24 👇

That’s 2 out of 2 success for this year’s OxCODE travel award winners in the #PrevConf24 poster prizes (guess we chose our candidates well 😊)! Congratulations to both Zhe Huang @Oxford_NDPH and @HollyEggington @HumanGeneticsOx @OxfordCancer

And huge congratulations to @HollyEggington for being the best early career researcher poster prize winner for the mechanistic theme!   A very worthy recipient of one of this year’s OxCODE travel awards! @OxfordCancer #PrevConf24

Great flash talk by @HollyEggington @HumanGeneticsOx on the potential of BMP4 activation for colorectal cancer prevention @OxfordCancer #PrevConf24

🎙️"Are population-based prevention studies fast enough?" @sarah_blagden says we need to rethink how we are designing studies and highlights @OCTO_Oxford - Oxford first UK centre to specialise in precision prevention & early detections trials. @UniofOxford | @SharonSavageMD | @theNCI |@CaPP3 | @UniofNewcastle | @ProfKarenBrown | @uniofleicester | #PrevConf24 (AB)

Oxford’s @sarah_blagden introducing precision prevention trials in people at higher risk of cancer, including the MILI trial for those with Li Fraumeni Syndrome #PrevConf24 @OxfordCancer @OCTO_Oxford @OxfordOncology

Special lecture from Sir Richard Peto @Oxford_NDPH (summarised by Sir John Burn) acknowledging the 70th anniversary of the discovery of the link between smoking and cancer in Oxford #PrevConf24 @OxfordCancer